持股变动声明
ZyVersa Therapeutics(ZVSA)07-19 09:45
$ZyVersa Therapeutics(ZVSA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-028403 Size: 14 KB 网页链接
简介：ZyVersa Therapeutics, Inc.于2014年3月11日根据佛罗里达州法律成立。他们是一家临床阶段的生物制药公司，利用专有技术为患有严重未满足医疗需求的慢性肾病或炎症性疾病的患者开发药物。他们有两个专利的全球授权药物开发平台，每个平台都是由迈阿密大学米勒医学院（“迈阿密大学”或“大学”）的研究科学家建立的。
| 今开：3.75 | 昨收：3.85 |
| 最高：3.9 | 最低：3.71 |
| 涨停价： | 跌停价： |
| 总市值：3214350 |
ZyVersa Therapeutics(ZVSA)07-19 09:45
$ZyVersa Therapeutics(ZVSA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-028403 Size: 14 KB 网页链接
ZyVersa Therapeutics(ZVSA)07-17 18:05
$ZyVersa Therapeutics(ZVSA)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-002174 Act: 33 Size: 1 KB 网页链接
ZyVersa Therapeutics(ZVSA)07-12 18:05
$ZyVersa Therapeutics(ZVSA)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001493152-24-027033 Act: 33 Size: 17 MB 网页链接
ZyVersa Therapeutics(ZVSA)07-19 09:45
$ZyVersa Therapeutics(ZVSA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-028402 Size: 14 KB 网页链接
ZyVersa Therapeutics(ZVSA)07-19 09:45
$ZyVersa Therapeutics(ZVSA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-028404 Size: 15 KB 网页链接
ZyVersa Therapeutics(ZVSA)07-19 09:45
$ZyVersa Therapeutics(ZVSA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-028401 Size: 15 KB 网页链接
ZyVersa Therapeutics(ZVSA)07-19 09:45
$ZyVersa Therapeutics(ZVSA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-028399 Size: 15 KB 网页链接
ZyVersa Therapeutics(ZVSA)07-19 09:45
$ZyVersa Therapeutics(ZVSA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-028400 Size: 15 KB 网页链接
ZyVersa Therapeutics(ZVSA)05-15 20:35
$ZyVersa Therapeutics(ZVSA)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001493152-24-019517 Act: 34 Size: 4 MB 网页链接
ZyVersa Therapeutics(ZVSA)07-19 09:45
$ZyVersa Therapeutics(ZVSA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-028405 Size: 5 KB 网页链接
不入流资讯2023-09-08 20:22
$ZyVersa Therapeutics(ZVSA)$ ZyVersa Therapeutics surges 43% premarket after Initiated at Buy by HC Wainwright & Co.查看全文
美股滚雪球2023-09-01 09:01
$ZyVersa Therapeutics(ZVSA)$ 同意以高达9100万美元的总对价收购$Acer医疗(ACER)$ ，后者是一家专注于罕见疾病的非上限生物技术公司。
根据协议条款，Zevra预计将发行296万股普通股，价值1500万美元。这笔交易还使ACER股东有权获得与至多7600万美元的额外现金支付挂钩的不可转让或有价值权(cv...查看全文
$ZyVersa Therapeutics(ZVSA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-028402 Size: 14 KB 网页链接
$ZyVersa Therapeutics(ZVSA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-028403 Size: 14 KB 网页链接
$ZyVersa Therapeutics(ZVSA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-028400 Size: 15 KB 网页链接
$ZyVersa Therapeutics(ZVSA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-028401 Size: 15 KB 网页链接
$ZyVersa Therapeutics(ZVSA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-028404 Size: 15 KB 网页链接
$ZyVersa Therapeutics(ZVSA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-028399 Size: 15 KB 网页链接
$ZyVersa Therapeutics(ZVSA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-24-028405 Size: 5 KB 网页链接
$ZyVersa Therapeutics(ZVSA)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-24-002174 Act: 33 Size: 1 KB 网页链接
$ZyVersa Therapeutics(ZVSA)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001493152-24-027033 Act: 33 Size: 17 MB 网页链接
$ZyVersa Therapeutics(ZVSA)$ 10-K/A [Amend] Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001493152-24-019511 Act: 34 Size: 455 KB 网页链接